These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 27076131

  • 21. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
    Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albariño CG.
    J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.
    Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, Smith J, Bouloy M.
    Am J Trop Med Hyg; 1995 Oct; 53(4):405-11. PubMed ID: 7485695
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC, Peters CJ.
    J Infect Dis; 2011 Jul 15; 204(2):229-36. PubMed ID: 21673033
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ.
    Vaccine; 2010 Jun 17; 28(27):4394-401. PubMed ID: 20434545
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H, Lorenzo G, Rodriguez F, Brun A.
    Vaccine; 2011 Jun 15; 29(27):4469-75. PubMed ID: 21549790
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.